Botulinum injections for myofascial pelvic pain
- 21 July 2020
- journal article
- research article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 32 (5) , 1151-1156
Abstract
Introduction and hypothesis The aim of this study was to assess the impact of botulinum toxin injection in women with myofascial pelvic pain (MFPP) syndrome of the pelvic floor who had failed conservative treatment. Methods This was a retrospective descriptive observational study of 48 consecutive patients receiving botulinum toxin to the pelvic floor for MFPP syndrome in a tertiary teaching hospital over an 8-year period. Trigger points were identified, and botulinum toxin was injected into the pelvic floor at the trigger points in doses ranging from 50 to 200 units. The patient-reported global impression of improvement scale was used to evaluate the success at follow-up, and adverse effects were recorded. Results Forty-six women attended for follow-up at 3–6 months. Of these, 34 (74%) reported an improvement in their symptoms (slightly better, much better, very much better), 12 (26%) had no change, and no patients reported worsening of symptoms. One patient (2%) reported transient postoperative faecal incontinence, which resolved after 2 weeks. There appeared to be no difference in outcome between the doses. Conclusions Botulinum toxin injection into the pelvic floor of women with MFPP appears to be beneficial in those who have failed conservative treatment. Prospective studies, including dose-finding studies, are now required.Keywords
This publication has 30 references indexed in Scilit:
- Botulinum Toxin Type A (BOTOX) for Refractory Myofascial Pelvic PainUrogynecology, 2013
- Biofeedback Is Superior to Electrogalvanic Stimulation and Massage for Treatment of Levator Ani SyndromeGastroenterology, 2010
- Pelvic Floor Muscle Assessment Outcomes in Women With and Without Provoked Vestibulodynia and the Impact of a Physical Therapy ProgramThe Journal of Sexual Medicine, 2010
- Botox Treatment for VaginismusPlastic and Reconstructive Surgery, 2009
- Gynecological indications for the use of botulinum toxin in women with chronic pelvic painToxicon, 2009
- Botulinum Toxin Type A—A Novel Treatment for Provoked Vestibulodynia? Results from a Randomized, Placebo Controlled, Double Blinded StudyThe Journal of Sexual Medicine, 2009
- Botulinum Toxin Type A Inhibits Calcitonin Gene-Related Peptide Release From Isolated Rat BladderJournal of Urology, 2006
- Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover studyPain, 2005
- Botulinum toxin in the treatment of myofascial pain syndromePain, 1994
- The validation of visual analogue scales as ratio scale measures for chronic and experimental painPain, 1983